Universe Pharmaceuticals Inc.
UPC · NASDAQ
3/31/2025 | 9/30/2024 | 3/31/2024 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $14 | $890 | $7,985 | $3,376 |
| - Cash | $47,273 | $29,498 | $8,862 | $5,285 |
| + Debt | $7,731 | $7,994 | $6,509 | $5,482 |
| Enterprise Value | -$39,528 | -$20,614 | $5,633 | $3,573 |
| Revenue | $9,153 | $10,140 | $12,884 | $13,842 |
| % Growth | -9.7% | -21.3% | -6.9% | – |
| Gross Profit | $3,165 | $2,827 | $3,245 | $4,063 |
| % Margin | 34.6% | 27.9% | 25.2% | 29.4% |
| EBITDA | -$2,886 | $4,694 | -$12,051 | -$3,806 |
| % Margin | -31.5% | 46.3% | -93.5% | -27.5% |
| Net Income | -$3,285 | $4,374 | -$13,101 | -$5,448 |
| % Margin | -35.9% | 43.1% | -101.7% | -39.4% |
| EPS Diluted | -944.4 | 719.79 | -2,155.91 | -919.74 |
| % Growth | -231.2% | 133.4% | -134.4% | – |
| Operating Cash Flow | $2,561 | -$7,077 | -$2,430 | -$3,640 |
| Capital Expenditures | -$97 | -$295 | -$68 | -$44 |
| Free Cash Flow | $2,464 | -$7,372 | -$2,497 | -$3,684 |